ARCHIVES

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

Cooperative Group Trials Approved By NCI Are Listed

August 26, 2005

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014

Sole Source Negotiations

March 7, 1975

In Brief: DOD Bill includes $135M For breast Cancer, $45M For prostate Cancer Technologies

October 3, 1997

HHS News: Skin Cancer Awareness Initiative Begun

May 29, 1998

NCCN Updates Breast Cancer Guidelines for Patients

October 31, 2003